Recent technologic advances indicate the potential role and applications of human
papillomavirus (HPV) DNA testing in the routine screening for cervical neoplasia, diagnostic …

Human papillomaviruses (HPVs) are the etiological agents of several genital cancers,
including cancer of the uterine cervix. The detection of HPV infection in genital samples may …

Cervical cancer continues to be a major epidemiologic problem in developed and
underdeveloped nations alike. Current screening practices rely on cervical cytology for the …

The identification in the early 1980s of human papillomavirus (HPV) DNA in cervical
carcinoma generated interest in molecular classification of the virus, and prompted studies …

Of the many types of human papillomavirus (HPV), more than 30 infect the genital tract. The
association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well …

The biological importance of a group of human papillomaviruses, known as high-risk human
papillomaviruses, as the key causal agent for almost all cervical cancer has now been …

Human papillomavirus DNA testing is gaining wider acceptance, yet the majority of testing is
still undertaken in the research setting using protocols that are unsuitable for clinical …

Cervical cancer is a largely preventable disease through the detection, treatment and follow-
up of its precursors. Traditionally, this has been accomplished through screening women …

Human papillomavirus (HPV) is a well-studied etiologic agent for cervical cancer dysplasia
and neoplasia. HPV E6 and E7 viral proteins drive oncogenesis by blocking the activity of …

Human Papillomavirus Testing in Cervical Cancer Screening - Obstetrics and Gynecology
Clinics Skip to Main Content Advertisement Obstetrics & Gynecology Clinics Log in Register Log …